Page 20 - Diagnostics Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tata Group in talks with Moderna to launch COVID-19 vaccine in India As per the government's norms, it is mandatory for a foreign vaccine-making firm to conduct at least a Phase-3 trial with Indian volunteers even if it is approved outside India BusinessToday.In | January 25, 2021 | Updated 11:00 IST Last year in January, Moderna received fundings from the Coalition for Epidemic Preparedness Innovations to develop a vaccine against the COVID-19 virus Tata Group's new healthcare venture, Tata Medical and Diagnostics Ltd (TataMD) has started exploratory talks with US biotechnology firm Moderna...

Active B12 Test Market Analysis 2021: Global Size, Product Share, Trends, Swot Analysis Forecast To 2023

Share this article Share this article ResearchAndMarkets.com's offering. Sepsis was killing over 30 million people a year with no definitive diagnostic in hand. And now the COVID-19 Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especially deaths related to COVID-19 infections. Understand the different drivers of this huge global diagn...